Pharmacokinetics, adverse effects and tolerability of a novel analogue of human pancreatic polypeptide, PP 1420

AIMS: The objectives of this phase 1 study were to confirm the tolerability of single ascending subcutaneous doses of PP 1420 in healthy subjects, to assess its adverse effects and to investigate the drug's pharmacokinetics and dose proportionality. METHODS: This was a double-blind, placebo-con...

詳細記述

保存先:
書誌詳細
主要な著者: Tan, Tricia M, Field, Benjamin C T, Minnion, James S, Cuenco-Shillito, Joyceline, Chambers, Edward S, Zac-Varghese, Sagen, Brindley, Charlie J, Mt-Isa, Shahrul, Fiorentino, Francesca, Ashby, Deborah, Ward, Ian, Ghatei, Mohammad A, Bloom, Stephen R
フォーマット: Artigo
言語:Inglês
出版事項: Blackwell Science Inc 2012
主題:
Pharmacokinetics
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3269582/
https://ncbi.nlm.nih.gov/pubmed/21834938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2011.04082.x
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料